COVID-19: FDA Grants Emergency Use Authorization for Eli Lilly’s Antibody Combo Therapy
On February 9th, Eli Lilly announced receiving the FDA’s emergency use authorization for its COVID-19 combination therapy comprising bamlanivimab and etesevimab. The approval was based on data from the Phase …
Read More